PROK — ProKidney Corp. | XLV Holdings | StockAdder

(PROK)

ProKidney Corp.

Live chart and latest PROK stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

PROK News

ProKidney (NASDAQ:PROK) Sees Strong Trading Volume - Time to Buy?

Apr 13, 2026 Yahoo Finance

What Makes ProKidney Corp. (PROK) So Attractive

Mar 31, 2026 Stock Titan

Cell therapy for kidney disease targets key FDA data by Q2 2027

Mar 18, 2026 Seeking Alpha

ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably (NASDAQ:PROK)

Jan 31, 2026 Forbes

ProKidney: What's Happening With PROK Stock?

Jul 9, 2025 Trefis

What’s Behind The 500% Rise In ProKidney Stock?

Jul 9, 2025 Investing.com

ProKidney stock soars after positive Phase 2 trial results

Jul 8, 2025 simplywall.st

April 2026 Penny Stock Highlights

Apr 3, 2026 GlobeNewswire

ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer

Mar 25, 2026 Yahoo Finance

ProKidney Corp. (PROK) Positioned to Redefine Chronic Kidney Disease Treatment, Believes H.C. Wainwright

Dec 27, 2025 Stock Titan

ProKidney hires ex-Shield CEO Greg Madison for rilparencel launch prep

Mar 25, 2026 MarketBeat

ProKidney (NASDAQ:PROK) Shares Up 5.9% - Here's Why

Mar 30, 2026 Yahoo Finance

ProKidney Corp. (PROK) is a Great Momentum Stock: Should You Buy?

Jul 16, 2025 Yahoo Finance

ProKidney Is Soaring on Trial Results. How Should You Play Penny Stock PROK Here?

Jul 8, 2025 Yahoo Finance

JP Morgan Maintains a Neutral Stance on ProKidney Corp. (PROK)